Gimsilumab Uses, Dosage, Side Effects and more
Gimsilumab is under investigation in clinical trial NCT01357759 (Safety and Tolerability of MORAb-022 in Healthy and Rheumatoid Arthritis Subjects).
| Trade Name | Gimsilumab |
| Generic | Gimsilumab |
| Gimsilumab Other Names | Gimsilumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
